Connection

Bonaventura Clotet to Adult

Back to Details
This is a "connection" page, showing publications Bonaventura Clotet has written about Adult.
Bonaventura Clotet
Connection Strength
0.146
Adult
  1. Pharmacokinetics of darunavir/cobicistat and etravirine alone and co-administered in HIV-infected patients. J Antimicrob Chemother. 2018 03 01; 73(3):732-737.
    View in: PubMed
    Score: 0.013
  2. Epidemiological, clinical, diagnostic and economic features of an immigrant population of chronic schistosomiasis sufferers with long-term residence in a non-endemic country (North Metropolitan area of Barcelona, 2002-2016). PLoS One. 2017; 12(9):e0185245.
    View in: PubMed
    Score: 0.012
  3. Pneumocystis jirovecii pneumonia in HIV-1-infected patients in the late-HAART era in developed countries. Scand J Infect Dis. 2013 Aug; 45(8):635-44.
    View in: PubMed
    Score: 0.009
  4. Variability in non-nucleoside reverse transcriptase and protease inhibitors concentrations among HIV-infected adults in routine clinical practice. Br J Clin Pharmacol. 2007 Jun; 63(6):715-21.
    View in: PubMed
    Score: 0.006
  5. Lopinavir/ritonavir plus nevirapine as a nucleoside-sparing approach in antiretroviral-experienced patients (NEKA study). J Acquir Immune Defic Syndr. 2005 Jan 01; 38(1):47-52.
    View in: PubMed
    Score: 0.005
  6. Hydroxychloroquine for Early Treatment of Adults With Mild Coronavirus Disease 2019: A Randomized, Controlled Trial. Clin Infect Dis. 2021 12 06; 73(11):e4073-e4081.
    View in: PubMed
    Score: 0.004
  7. High-dose intravenous immunoglobulins might modulate inflammation in COVID-19 patients. Life Sci Alliance. 2021 09; 4(9).
    View in: PubMed
    Score: 0.004
  8. Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals. Viruses. 2021 06 12; 13(6).
    View in: PubMed
    Score: 0.004
  9. Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trial. Lancet Infect Dis. 2021 10; 21(10):1365-1372.
    View in: PubMed
    Score: 0.004
  10. Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study. Lancet Infect Dis. 2021 05; 21(5):629-636.
    View in: PubMed
    Score: 0.004
  11. SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity. Sci Rep. 2021 01 28; 11(1):2608.
    View in: PubMed
    Score: 0.004
  12. A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19. N Engl J Med. 2021 02 04; 384(5):417-427.
    View in: PubMed
    Score: 0.004
  13. Outcome of hospitalized patients with COVID-19 pneumonia treated with high-dose immunoglobulin therapy in a prospective case series. Clin Microbiol Infect. 2021 Apr; 27(4):651-652.
    View in: PubMed
    Score: 0.004
  14. Routine Screening of Anal Cytology in Persons With Human Immunodeficiency Virus and the Impact on Invasive Anal Cancer: A Prospective Cohort Study. Clin Infect Dis. 2020 07 11; 71(2):390-399.
    View in: PubMed
    Score: 0.004
  15. NEU Screen Shows High Accuracy in Detecting Cognitive Impairment in Older Persons Living With HIV. J Assoc Nurses AIDS Care. 2019 Jan-Feb; 30(1):35-41.
    View in: PubMed
    Score: 0.003
  16. Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort. AIDS. 2018 10 23; 32(16):2405-2416.
    View in: PubMed
    Score: 0.003
  17. Mechanisms That Contribute to a Profound Reduction of the HIV-1 Reservoir After Allogeneic Stem Cell Transplant. Ann Intern Med. 2018 11 20; 169(10):674-683.
    View in: PubMed
    Score: 0.003
  18. Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study. Lancet HIV. 2018 11; 5(11):e638-e646.
    View in: PubMed
    Score: 0.003
  19. High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs. J Antimicrob Chemother. 2018 09 01; 73(9):2452-2459.
    View in: PubMed
    Score: 0.003
  20. Incidence of cervical high-grade squamous intraepithelial lesions in HIV-1-infected women with no history of cervical pathology: up to 17 years of follow-up. Int J STD AIDS. 2019 01; 30(1):56-63.
    View in: PubMed
    Score: 0.003
  21. Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection. Mucosal Immunol. 2019 01; 12(1):232-246.
    View in: PubMed
    Score: 0.003
  22. Effectiveness of physically ablative and pharmacological treatments for anal condyloma in HIV-infected men. PLoS One. 2018; 13(8):e0199033.
    View in: PubMed
    Score: 0.003
  23. CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir. Nat Commun. 2018 07 16; 9(1):2739.
    View in: PubMed
    Score: 0.003
  24. High Prevalence of Sarcopenia in HIV-Infected Individuals. Biomed Res Int. 2018; 2018:5074923.
    View in: PubMed
    Score: 0.003
  25. Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial. J Antimicrob Chemother. 2018 07 01; 73(7):1965-1971.
    View in: PubMed
    Score: 0.003
  26. Impact of intensification with raltegravir on HIV-1-infected individuals receiving monotherapy with boosted PIs. J Antimicrob Chemother. 2018 07 01; 73(7):1940-1948.
    View in: PubMed
    Score: 0.003
  27. Recurrent coronary disease in HIV-infected patients: role of drug-drug interactions. Br J Clin Pharmacol. 2018 07; 84(7):1617-1619.
    View in: PubMed
    Score: 0.003
  28. Memory B cell dysregulation in HIV-1-infected individuals. AIDS. 2018 Jan 14; 32(2):149-160.
    View in: PubMed
    Score: 0.003
  29. Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4+ T-cell immune recovery. PLoS One. 2017; 12(9):e0184433.
    View in: PubMed
    Score: 0.003
  30. Preserved immune functionality and high CMV-specific T-cell responses in HIV-infected individuals with poor CD4+ T-cell immune recovery. Sci Rep. 2017 09 15; 7(1):11711.
    View in: PubMed
    Score: 0.003
  31. Transdermal rivastigmine for HIV-associated cognitive impairment: A randomized pilot study. PLoS One. 2017; 12(8):e0182547.
    View in: PubMed
    Score: 0.003
  32. Plasma HIV-1 Tropism and the Risk of Short-Term Clinical Progression to AIDS or Death. PLoS One. 2017; 12(1):e0166613.
    View in: PubMed
    Score: 0.003
  33. Reduced darunavir dose is as effective in maintaining HIV suppression as the standard dose in virologically suppressed HIV-infected patients: a randomized clinical trial. J Antimicrob Chemother. 2015 Apr; 70(4):1139-45.
    View in: PubMed
    Score: 0.003
  34. Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe. BMC Infect Dis. 2014 Jul 21; 14:407.
    View in: PubMed
    Score: 0.002
  35. Stable HIV-1 integrase diversity during initial HIV-1 RNA decay suggests complete blockade of plasma HIV-1 replication by effective raltegravir-containing salvage therapy. Virol J. 2013 Dec 05; 10:350.
    View in: PubMed
    Score: 0.002
  36. Safety of enfuvirtide in combination with an optimized background of antiretrovirals in treatment-experienced HIV-1-infected adults over 48 weeks. J Acquir Immune Defic Syndr. 2005 Dec 01; 40(4):413-21.
    View in: PubMed
    Score: 0.001
  37. Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trial. Ann Intern Med. 2003 Jul 15; 139(2):81-9.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.